MMedication Read More Common allergy medication’s risks outweigh its usefulness, experts sayAugust 8, 2025 AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
MMedication Read More Common allergy medication’s risks outweigh its usefulness, experts sayAugust 2, 2025 AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
HHealth Read More Chemotherapy Linked to Brain Atrophy in BreastAugust 1, 2025 Patients with breast cancer who undergo chemotherapy may face an increased risk for brain atrophy and cognitive decline,…
MMental health Read More Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goalJuly 30, 2025 atai Life Sciences (ATAI) company Recognify Life Sciences has reported that its Phase IIb trial of oral compound,…